# Terazosin

## Telowsin 2mg

##### 

| TAH Drug Code      | OTELO                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|:-------------------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Hypertension, benign prostatic hyperplasia (BPH).                                                                                                                                                                                                                                                                                                                                                                                                       |
| Dosing             | Benign prostatic hyperplasia: initially 1 mg at bedtime, increase dose in a stepwise fasion to 2 mg, 5 mg, or 10 mg once daily to achieve desired improvement. If no response after 4-6 weeks of 10 mg once daily, may increase to a maximum dose of 20 mg once daily. Hypertension: initially 1 mg at bedtime, then titrate gradually, as needed, based on response and tolerability up to 20 mg/day in 1 or 2 divided doses. Usual dosage: 1-5 mg QD. |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                           |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                           |
| Contraindications  | Hypersensitivity to terazosin or any component of the formulation                                                                                                                                                                                                                                                                                                                                                                                       |
| Adverse Effects    | Dizziness, nasal congestion, drowsiness, nausea, peripheral edema, asthenia, postural hypotension.                                                                                                                                                                                                                                                                                                                                                      |
| Pregnancy          | No (Limited) Human Data â€“ Animal Data Suggest Low Risk                                                                                                                                                                                                                                                                                                                                                                                                  |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                           |

